Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on TALANX AG. We currently have 6 research reports from 1 professional analysts.
Frequency of research reports
Research reports on
Good Q3 results and new but unambitious FY2017 target
15 Nov 16
Net attributable profit increased by 32% to €234m for Q3 16 compared to Q3 15. Net premiums earned declined by 3% to €6.3bn for Q3 16 compared to the same period last year. The net investment result was up by 7% to €1.02bn for Q3 16. RoI was 3.5% for 9M 16 compared to 3.7% for 9M 15. Insurance claims decreased by 5% to €5.2bn in Q3 16 compared to Q3 15. The group net combined ratio of the non-life business was 96.4% for Q3 16 compared to 98.0% for Q3 15. Pre-tax profit rose by 20% to €548m for Q3 16. Equity capital attributable to common shares increased by 9% to €9.0bn at the end of September 2016 compared to the end of 2015. Talanx slightly raised its outlook for group net income for 2016 from “approximately” to “at least” €750m. Additionally, Talanx released a net profit target for FY2017 for the first time. It is looking to generate group net attributable profit of again at least €750m for FY2017.
Q2 figures in line with expectations and guidance
12 Aug 16
Net attributable profit tripled from €60m for Q2 15 to €179m for Q2 16 due to a goodwill impairment of €155m on the German life business in Q2 15. Net premiums earned were up by 2.5% to €6.5bn for Q2 16 compared to Q2 15. The net investment result declined by 10% to €940m for Q2 16. Insurance claims were up by 1% to €5.3bn in Q2 16. The group’s net combined ratio of the non-life business increased from 96.2% for Q2 15 to 97.3% for Q2 16. Pre-tax profit was up by 39% to €455m for Q2 16 compared to the same period last year. Equity capital attributable to common shares rose by 4.5% to €8.65bn at the end of June 2016 compared to the end of 2015 due to higher unrealised gains. RoE was 8.4% for Q2 16 versus 2.8% for Q2 15. Talanx confirmed its net attributable profit target for FY2016 of €750m. The Solvency II stood at 171% at the end of 2015.
Solid start to 2016
13 May 16
Net attributable profit decreased by 12% to €222m for Q1 16 compared to Q1 15 which benefited from a special effect of €19m net. Net premiums earned were down by 1.5% to €6.3bn for Q1 16 compared to the same period last year. The net investment result rose by 3% to €1.02bn for Q1 16. RoI was around 3.7% for Q1 16 compared to 3.6% in Q1 15. Insurance claims declined by 2.2% to €5.2bn in Q1 16 compared to Q1 15. Group net combined ratio of the non-life business was 96.3% for Q1 16 compared to 96.5% for Q1 15. Pre-tax profit decreased by 10% to €536m for Q1 16. RoE after tax was 10.6% for Q1 16 compared to 12.0% for Q1 15. Equity capital attributable to common shares increased by 3% to €8.5bn at the end of March 2016 compared to the end of 2015. Talanx confirmed its net attributable profit target for FY2016 of €750m. The Solvency II stood at 171% at the end of 2015.
Good FY2015 figures and a slightly increased dividend proposal
21 Mar 16
Net attributable profit decreased by 5% to €734m for FY2015 compared to FY2014. Net premiums earned rose by 9% to €25.9bn for 2015 compared to 2014 and were up by around 4.5% at constant currency. The net investment result was down by 5% to €3.9bn for 2015. RoI was around 3.6% for 2015 compared to 4.1% in 2014 which benefited from the sale of a Swiss Life stake. Insurance claims were up by 7% to €21.44bn in 2015 compared to 2014. Group net combined ratio of the non-life business declined from 97.9% for 2014 to 96.0% for 2015. Operating profit before goodwill impairments increased by 24% to €2.34bn for FY2015. A goodwill impairment of €155m on the German life business (Q2 15) burdened the 2015 result. Pre-tax profit rose by 18% to €2.0bn for 2015. The tax ratio was 28% for FY2015 compared to 18% for 2014 which benefited from a tax-free disposal gain and the release of provisions for deferred taxes. Equity capital attributable to common shares increased by 3.6% to €8.3bn at the end of 2015 compared to the end of 2014. RoE was 9.0% for FY2015 compared to 10.2% for FY2014. The dividend proposal increased from €1.25 per share for FY2014 to €1.30 per share for FY2015. Talanx increased the net profit target from more than €700m to around €750m for FY2016. The capital resources of the Talanx Group in accordance with Solvency I stood at 219% at the end of 2015 compared to 228% at the end of 2014.
Solid Q3 figures and new disappointing FY2016 target
12 Nov 15
Net attributable profit increased by 19% to €177m for Q3 15 compared to Q3 14. Net premiums earned rose by 11.5% to €6.5bn for Q3 15 compared to the same period last year. The net investment result was down by 9% to €952m for Q3 15. RoI was around 3.3% for Q3 15 compared to 4.0% in Q3 14. Insurance claims were up by 9.5% to €5.4bn in Q3 15 compared to Q3 14. Group net combined ratio of the non-life business was 98.0% for Q3 15 compared to 100.0% for Q3 14. Pre-tax profit rose by 15% to €455m for Q3 15. Equity capital attributable to common shares increased by 1% to €8.1bn at the end of September 2015 compared to the end of 2014. Talanx released a net profit target for FY2016 for the first time. It is looking to generate group net attributable profit of more than €700m for FY2016. The capital resources of the Talanx Group in accordance with Solvency I stood at 227.5% compared to 228.2% at the end of 2014.
Good Q2 figures burdened by impairments
12 Aug 15
Net attributable profit decreased from €165m for Q2 14 to €60m for Q2 15 due to a goodwill impairment of €155m on the German life business. Gross written premiums were up by 13% to €6.6bn for Q2 15 compared to Q2 14. The net investment result rose by 11% to €1.04bn for Q2 15. Insurance claims were up by 16% to €5.3bn in Q2 15. The group's net combined ratio of the non-life business decreased from 98.4% for Q2 14 to 96.2% for Q2 15. Equity capital attributable to common shares was flat at €8.0bn at the end of June 2015 compared to the end of 2014. Group solvency was therefore 223.5% at the end of Q2 15 compared to 228% at the end of 2014. RoE was 2.8% for Q2 15 versus 8.7% for Q2 14.
Making Mobiles Better
17 Jan 17
Mobile phones are increasingly the key connection for the modern world. This means that the performance of mobile phones, and their networks, is going to become more critical for all the apps and businesses that rely on them. New technologies such as VR, AR, and AV will need better, more reliable connections to really move into the mainstream. In this thematic piece we attempt to identify some of the most important issues facing mobile phone networks and their users, and start to identify solutions and enablers that will solve these problems and create value by doing so.
The Monthly January 2017
09 Jan 17
Despite all the hullaballoo of the Brexit vote and the subsequent election of Donald Trump as the next US President, the UK stock market prospered last year, especially in the latter few months of 2016. The combination of a depreciating currency – making $ earnings more valuable in relative terms - and the Trump emphasis on infrastructure expenditure drove the stock market higher
Small Cap Breakfast
17 Jan 17
Global Energy Development (GED.L) — To be renamed Nautilus Marine Services. Schedule 1 from developer and seller of hydrocarbons and related products. Reverse takeover. Raising $10.5m via a convertible. Expected 9 Feb. Eco (Atlantic) Oil & Gas—TSX-V listed oil and gas exploration has announced its intention to float on AIM. Assets in Guyana and Namibia. Proposed £2m-£3m fundraise. Diversified Gas & Oil—According to LSE website first day of trading on AIM now expected for 30 January.
N+1 Singer - Northern lights - Shining prospects for 2017
16 Jan 17
As the birthplace of Stephenson, Armstrong and Swan, the North East of England has a proud history of industrial and technological innovation. Despite local economic challenges, the region’s industrial heritage lives on through continuing success in high end engineering and technology. The recent takeovers of private equity backed SMD (subsea robotics) and Nomad Digital (wi-fi on the railways) are testament to this. The North East has also emerged as a leader in genetics and genomics with an enviable life sciences and healthcare infrastructure. Against this backdrop, we expect the region to continue to throw up attractive IPO candidates to build on the six new listings in the past three years. We expect 2017 to be far kinder to the existing portfolio of North East plcs than 2016 (a year to forget) with recent management changes one important theme for the new year. Our top picks are Hargreaves Services, Quantum Pharma and Zytronic (all N+1 Singer Corporate clients) and we are Buyers of Northgate and Grainger.
N+1 Singer - Morning Song 19-01-2017
19 Jan 17
Actual Experience (ACT LN) 2017 – a milestone year for revenue | Bagir Group (BAGR LN) Independent NED appointment to strengthen Board composition | Bioquell (BQE LN) Reassuring pre-close statement | Carador Income Fund (CIFU LN) Q4 dividend increased to 2.75c, 0.5c higher than forecast | FreeAgent (FREE LN) Contract with Royal Bank of Scotland | Halfords Group (HFD LN) Excellent Q3 update, special divi and confidence in FX mitigations | N Brown Group (BWNG LN) Robust peak trading with reversal of drag from older titles | NCC Group (NCC LN) Interims confirm underlying business sound | St Ives (SIV LN) Downgrade | Summit Therapeutics (SUMM LN) Dr David Roblin appointed Chief Operating Officer and R&D President | Wilmington Group (WIL LN) Acquisition – Further scaling of Healthcare
What a year it was!
16 Jan 17
2016 got off to a rocky start. Not long into January, after just a few trading days, global equity markets lost more than US$4tn of value due to investor sentiment towards China’s economic slowdown and depreciating currency. This was immediately followed by a slump in the oil price. By the third week of January, Brent Crude hit its year low at $27.10 a barrel causing an immediate sell off in the energy sector. Once the Q1 dust had settled, attention turned to the UK’s vote on whether to remain a member of the EU. The Brexit vote result proved to be a genuine shock for markets, with many investors having believed that the UK would stay within the European Union. Attention soon turned to the equally ill-tempered US Presidential elections and all the political and economic unknowns that Trump’s victory has spawned. As a result, AIM, has seen a roller-coaster of a year in 2016.